Open to download resource.
Heidi Connolly, MD
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN
There are no conflicts of interest to disclose.
1. Describe the physiologic cardiovascular changes of pregnancy.
2. Describe the most common cardiac events associated with congenital heart disease (CHD)
3. Understand the indications for infective endocarditis prophylaxis.
4. Describe lesion specific care for pregnant people with CHD.
1. Regitz‐Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur. Heart J. 2011;32(24):3147‐97.
2. S, Sermer M, Colman J, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515‐521.
3. Bedard E, Dimopoulos K, Gatzoulis M a. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur. Heart J. 2009;30(3):256‐265.
4. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of Pregnancy in Women With Congenital Heart Disease. A Literature Review. J. Am. Coll. Cardiol. 2007;49(24):2303‐2311.
5. Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur. Heart J. 2010;31(17):2124‐2132. .
6. Drenthen W, Pieper PG, van der Tuuk K, et al. Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur. Heart J. 2005;26(23):2581‐2587.
7. Yap S‐C, Drenthen W, Pieper PG, et al. Pregnancy outcome in women with repaired versus unrepaired isolated ventricular septal defect. BJOG. 2010;117(6):683‐689.
8. Yap S‐C, Drenthen W, Meijboom FJ, et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG. 2009;116(12):1593‐1601.
9. W, Taubert K a, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Co. Circulation. 2007;116(15):1736‐54.